NewGenIvf Group Limited — Form 6-K
Reporting date: October 7, 2026. The company, a foreign private issuer, furnished unaudited condensed consolidated financial statements for the six months ended June 30, 2026, including a balance sheet as of June 30, 2026. The filing identifies NewGenIvf Group Limited and lists its principal executive offices in Bangkok, Thailand.
Financial information
The supplied filing text does not include the financial statements in Exhibit 99.1. Revenue, profit or loss, cash flow, margins, debt, liquidity, and other financial metrics therefore cannot be determined from this text.
Changes, outlook, and risks
No prior-period comparisons, guidance, management commentary, risk disclosures, contingencies, or unusual items are provided in the supplied text.
Facts to verify
- Review Exhibit 99.1 for the actual results and balance-sheet figures; it is referenced but not included in the supplied text.
- Verify the financial statements’ comparative-period data and any accompanying notes or disclosures.